You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial

Article info

Article menu

Download PDFPDF

XML
Rheumatology
Protocol
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial

Authors

  • Siegfried Kohler Department of Experimental Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany Department of Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany Neurocure Clincal Research Center, Charite Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Stefanie Märschenz Neurocure Clincal Research Center, Charite Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Ulrike Grittner Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Tobias Alexander Department of Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Falk Hiepe Department of Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Andreas Meisel Department of Experimental Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany Department of Neurology, Charité – Universitätsmedizin Berlin, Berlin, Germany Neurocure Clincal Research Center, Charite Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Siegfried Kohler; siegfried.kohler{at}charite.de
View Full Text

Citation

Kohler S, Märschenz S, Grittner U, et al
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial
BMJ Open 2019;9:e024523. doi: 10.1136/bmjopen-2018-024523

Publication history

  • Received May 30, 2018
  • Revised November 27, 2018
  • Accepted December 7, 2018
  • First published January 28, 2019.
Online issue publication 
January 13, 2021
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.